FT  22 JUN 93 / UK Company News: Amersham Intl
Amersham International, the health science group, has received US marketing
approval for Metastron, its injectable radiopharmaceutical, from the Food
and Drug Administration.
Earlier this year, Amersham joined with Zeneca to co-promote the drug, which
helps control pain of secondary cancer that has spread to the bone.
